Answers are grounded in this paper and cite their sources.
Transcranial magnetic stimulation (TMS) is a neuromodulation technology capable of targeted stimulation and inhibition of cortical areas of the brain. Currently, TMS has established itself as a method with proven effectiveness in the treatment of some psychoneurological disorders in children. In this regard, there is increasing interest in studying new options for the use of TMS in patients with acute and chronic neurological deficits. In children with brain tumors, up to 90 % of neurological disorders are determined. However, to date, there is insufficient data on the use of TMS technology in pediatric oncological neurorehabilitation.
No takes yet. Share an insight, caveat, or question.
Kharbediya et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: